Regeneron Research Poster

News

Regeneron To Buy 23andMe For $256M After Bankruptcy

Regeneron Pharmaceuticals to buy 23andMe for $256M

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March following a series of setbacks.

Investopedia on MSN · 2d

Regeneron Buys 23andMe in Bankruptcy Auction

Regeneron Pharmaceuticals agreed to buy DNA testing company 23andMe in a bankruptcy court auction, the company said Monday.

UPI on MSN · 2d

Regeneron Pharmaceuticals to pay $256 million for 23andMe in bankruptcy sale

Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy protection in a $256 million deal.

14h

Regeneron's 23andMe Steal - Smart Genetics Play That Won't Cure Near-Term Growth Pains

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

MedCity News2d

23andMe Bankruptcy Auction Win Adds Big Piece to Regeneron’s Gene-Based Drug R&D Efforts

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

Yahoo Finance2d

Regeneron buys bankrupt 23andMe for $256m

the auction will see Regeneron acquire the majority of 23andMe’s assets. This includes the company’s Personal Genome Service (PGS) and Total Health and Research Services business lines ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Regeneron To Buy 23andMe For $256M After Bankruptcy

Trending now